This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gillette, R. W. Articles by Boone, C. W. Search for Related Content PubMed PubMed Citation Articles by Gillette, R. W. Articles by Boone, C. W.

Changes in the Mitogen Response of Lymphoid Cells with Progressive Tumor Growth¹

Meloy Laboratories, Inc., Springfield, Virginia 22151 [R. W. G.], and Cell Biology Section, National Cancer Institute, NIH, Bethesda, Maryland 20014 [C. W. B.]

The response of spleen and lymph node cells from tumor-bearing animals to a variety of mitogens was measured. It was found that progressive tumor growth diminished the reactivity of spleen cells to the mitogen phytohemagglutinin. Lymph node cells from the same animal were not consistently so affected. The reactivity of spleen cells from tumor-bearing donors to concanavalin A was somewhat depressed, while stimulation by bone marrow-derived lymphocyte mitogens such as endotoxin and pokeweed mitogen was in some cases enhanced. Antigen expression in tumor bearer spleens was found to decline steadily after 7 days of tumor growth. Cytological analysis revealed that the normal structure of the spleens of tumor animals was infiltrated by myeloid elements. The changes described occurred regardless of whether the tumors were chemically or virally induced. Excision of tumors after long periods of growth resulted in prompt return of splenic phytohemagglutinin sensitivity. The data suggest that loss or incapacitation of parts of the normal thymus-derived lymphocyte components may occur in the spleens of animals with progressive neoplastic growth.

¹ Supported by Contract NCI-72-2020 to Meloy Laboratories, Inc., from the Virus Cancer Program of the National Cancer Institute.

Received 12/18/74. Accepted 9/ 8/75.